Skip to main content

HSV Latency In Vitro

In Situ Hybridization Methods

  • Protocol
Herpes Simplex Virus Protocols

Part of the book series: Methods in Molecular Medicine ((MIMM,volume 10))

Abstract

We have developed an in vitro model of herpes simplex virus (HSV) latency in primary neurons that mimics many aspects of HSV latency in animal models and the human disease (13). Using this model, we demonstrated that HSV-1 and HSV-2 establish latent infections in vitro in the same neuronal cell types that are shown to harbor latent HSV in humans (3). Latent HSV infections can be produced in neuronal cultures from ganglia of rodents and primates with similar results (3). In all cases examined, the neurotrophin, nerve growth factor (NGF), is required to maintain the latent infections. Depletion of NGF results in the reactivation of latent virus (13). Depending upon the conditions and the use of a high multiplicity of infection, latent HSV-1 infections are established in the majority of primary sensory or sympathetic neurons in tissue culture (2,4). To achieve high efficiency of establishment of latency with little or no evidence of lytic infection, an antiviral agent (e.g., acyclovir) is added to the neuronal cultures during the first week after inoculation with virus. However, latency can be established in the absence of antiviral treatment provided that the multiplicity of infection (MOI) is very low (1,2). At least one of the actions of the antiviral treatment is to prevent amplification of the input virus in the nonneuronal cells that are present in the culture at the outset of the infection. These nonneuronal cells are destroyed in the presence of acyclovir and virus (4). Latency is maintained in neurons in culture for as long as 10 wk in the presence of NGF. Viral transcripts and antigens associated with the productive infection are not detected during the latent infection (2,3,5). Viral transcription is restricted to the latency-associated transcripts (LAT) during the latent infection and is present in the nuclei of 80–90% of the neurons by 3 wk postinfection (4,5) Upon removal of NGF from the culture medium, for as brief as 1 h, reactivation of latent virus is induced (3), and viral antigens associated with the productive infection and infectious virus are detected between 48–72 h after NGF deprivation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wilcox, C. L. Johnson, E. M. (1987) Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J. Virol. 61, 2311–2315.

    PubMed  CAS  Google Scholar 

  2. Wilcox, C. L. Johnson, E. M., Jr. (1988) Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J. Virol. 62, 393–399.

    PubMed  CAS  Google Scholar 

  3. Wilcox, C. L., Smith, R. L., Freed, C., and Johnson, E. M. (1990) Nerve growth factor-dependence of herpes simplex latency in peripheral sympathetic and sensory neurons in vitro. J. Neurosci. 10, 1268–1275.

    PubMed  CAS  Google Scholar 

  4. Smith, R. L., Escudero, J. L., and Wilcox, C. L. (1994) Regulation of the herpes simplex virus latency-associated transcript during establishment of latency in sensory neurons in vitro. Virology 202, 49–60.

    Article  PubMed  CAS  Google Scholar 

  5. Doerig, C., Pizer, L. I., and Wilcox, C. L. (1991) Detection of the latency-associated transcript on neuronal cultures during the latent infection with herpes simplex virus type 1. Virology 63, 423–426.

    Article  Google Scholar 

  6. Smith, R. L., Pizer, L. I., Johnson, E. M., Jr., and Wilcox, C. L. (1992) Activation of second-messenger pathways reactivates latent herpes simplex virus in neuronal cultures. Virology 188, 311–318.

    Article  PubMed  CAS  Google Scholar 

  7. Baringer, J R. (1974) Recovery of herpes simplex virus from human sacral ganglions N Engl. J Med 291, 828–830

    CAS  Google Scholar 

  8. Smith, R. L. and Wilcox, C. L. Gene transfer into neurons towards gene therapy of neurological diseases (Lowenstein, P and Enquist, L., eds.), Wiley, Sussex, UK, in press

    Google Scholar 

  9. Sambrock, J, Fritch, E. F, and Maniatis, T (1989) Molecular Cloning A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

    Google Scholar 

  10. Fraser, N I, Block, T M, and Spivack, J G. (1992) The latency-associated transcripts of herpes simplex virus: RNA in search of a function. Virology 191, 1–8

    Article  PubMed  CAS  Google Scholar 

  11. Arthur, J., Efstathiou, S, and Simmons, A. (1993) Intranuclear foci containing low abundance herpes simplex virus latency-associated transcripts visualized by non-isotopic in situ hybridizations. J. Gen. Virol, 74, 1363–1370.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Wilcox, C.L., Smith, R.L. (1998). HSV Latency In Vitro. In: Brown, S.M., MacLean, A.R. (eds) Herpes Simplex Virus Protocols. Methods in Molecular Medicine, vol 10. Humana Press. https://doi.org/10.1385/0-89603-347-3:317

Download citation

  • DOI: https://doi.org/10.1385/0-89603-347-3:317

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-347-4

  • Online ISBN: 978-1-59259-594-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics